Summary
For Year 2026-27, Windlas Biotech reports the following shareholding: Total Promoters at 61.9%, Mutual Fund at 7.08%, Insurance at 0%, Foreign Institutional Investors at 0.6%, Domestic Institutional Investors at 4.73%, and Retail at 25.7%. This breakdown provides a quick snapshot of ownership distribution for Windlas Biotech in 2026-27.
Windlas Biotech FAQs
As of 04-2026, the promoter shareholding in Windlas Biotech stands at 61.9% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Windlas Biotech is 0.6% and 4.73% respectively.
The retail shareholding of the Windlas Biotech is 25.7%.
Changes in shareholding patterns of Windlas Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Windlas Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
